These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33528923)

  • 1. Have asthma symptoms in Mexico changed in the past 15 years? Time trends from the International Study of Asthma and Allergies in Childhood to the Global Asthma Network.
    Estela DB; Arturo B; Nayely RN; Maureen NE; Roberto GA; Valente MJ; Philippa E; Luis GÁ
    Allergol Immunopathol (Madr); 2021; 49(1):1-10. PubMed ID: 33528923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.
    Strachan DP; Rutter CE; Asher MI; Bissell K; Chiang CY; El Sony A; Ellwood E; Ellwood P; García-Marcos L; Marks GB; Morales E; Mortimer K; Pearce N; Pérez-Fernández V; Robertson S; Silverwood RJ;
    Pediatr Allergy Immunol; 2022 Jan; 33(1):e13656. PubMed ID: 34453861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I.
    Navarrete-Rodríguez EM; Del-Río-Navarro BE; Reyes Noriega N; Berber A; Mérida Palacio V; García-Almaráz R; Ellwood P;
    World Allergy Organ J; 2022 Nov; 15(11):100710. PubMed ID: 36267354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study.
    Asher MI; Rutter CE; Bissell K; Chiang CY; El Sony A; Ellwood E; Ellwood P; García-Marcos L; Marks GB; Morales E; Mortimer K; Pérez-Fernández V; Robertson S; Silverwood RJ; Strachan DP; Pearce N;
    Lancet; 2021 Oct; 398(10311):1569-1580. PubMed ID: 34755626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of symptoms, severity and diagnosis of asthma in adolescents in the Province of Salamanca, Spain: Global Asthma Network (GAN) Phase I.
    Marín-Cassinello A; Vega-Hernández MC; Lumbreras-Lacarra B; De Arriba-Méndez S; Pellegrini-Belinchón J
    Allergol Immunopathol (Madr); 2021; 49(5):106-112. PubMed ID: 34476930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations-a cross-sectional study.
    Del-Río-Navarro BE; Berber A; Reyes-Noriega N; Navarrete-Rodríguez EM; García-Almaraz R; Ellwood P; Garcia-Marcos L; Saucedo-Ramírez OJ; Mérida-Palacio VJ; Ramos-García BDC; Escalante-Domínguez AJ; Linares-Zapién FJ; Moreno-Gardea HL; Ochoa-López G; Hernández-Mondragón LO; Lozano-Sáenz JS; Sacre-Hazouri JA; Juan-Pineda Á; Sánchez-Coronel MG; Rodríguez-Pérez N; Ambriz-Moreno MJ;
    BMJ Open Respir Res; 2020 Dec; 7(1):. PubMed ID: 33268340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Ellwood P; Asher MI; Billo NE; Bissell K; Chiang CY; Ellwood EM; El-Sony A; García-Marcos L; Mallol J; Marks GB; Pearce NE; Strachan DP
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28077477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased prevalence and severity of asthma symptoms among adolescents in Ibadan, Nigeria, 1995-2018.
    Labaeka AA; Falade AG; Addo-Yobo EOD; Mortimer K; Zurba L; Lesosky M; Ellwood P; Asher MI
    Int J Tuberc Lung Dis; 2023 Dec; 27(12):925-930. PubMed ID: 38042979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase I.
    García-Almaraz R; Reyes-Noriega N; Del-Río-Navarro BE; Berber A; Navarrete-Rodríguez EM; Ellwood P; García Marcos Álvarez L;
    World Allergy Organ J; 2021 Jan; 14(1):100492. PubMed ID: 34659624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and temporal evolution of asthma symptoms in Spain. Global Asthma Network (GAN) study.
    Bercedo Sanz A; Martínez-Torres A; González Díaz C; López-Silvarrey Varela Á; Pellegrini Belinchón FJ; Aguinaga-Ontoso I; García-Marcos L;
    An Pediatr (Engl Ed); 2022 Sep; 97(3):161-171. PubMed ID: 35906153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee.
    Asher MI; Weiland SK
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():52-66; discussion 90-1. PubMed ID: 9988448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooking fuels and prevalence of asthma: a global analysis of phase three of the International Study of Asthma and Allergies in Childhood (ISAAC).
    Wong GW; Brunekreef B; Ellwood P; Anderson HR; Asher MI; Crane J; Lai CK;
    Lancet Respir Med; 2013 Jul; 1(5):386-94. PubMed ID: 24429203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of bronchodilator reversibility with albuterol, between asthma symptomatic and asymptomatic children according to ISAAC questionnaire in Mexico City.
    Del Río-Navarro BE; Hernández-Román MP; Espinola Reyna G; Berber A; Escalante-Domínguez AJ; González-Reyes M; Rosas-Vargas MA; Pérez-Lopez J; Baeza-Bacab M; Sienra-Monge JJ
    Allergol Immunopathol (Madr); 2004; 32(6):334-9. PubMed ID: 15617660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Asthma Network Phase I Surveillance: Geographical Coverage and Response Rates.
    Ellwood P; Ellwood E; Rutter C; Perez-Fernandez V; Morales E; García-Marcos L; Pearce N; Asher MI; Strachan D; On Behalf Of The Gan Phase I Study Group
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33212975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and time trends of symptoms of allergic rhinitis and rhinoconjunctivitis in Spanish children: Global Asthma Network (GAN) study.
    Bercedo-Sanz A; Martínez-Torres A; Varela AL; Belinchón FJP; Aguinaga-Ontoso I; Díaz CG; García-Marcos L; Spain GG
    Allergol Immunopathol (Madr); 2023; 51(5):1-11. PubMed ID: 37695222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of asthma in an inner-city area: A historical review 10 years after Isaac.
    Del-Rio-Navarro BE; Navarrete-Rodríguez EM; Berber A; Reyes-Noriega N; García-Marcos Álvarez L;
    World Allergy Organ J; 2020 Jan; 13(1):100092. PubMed ID: 31934263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Asthma Network Phase I Syria asthma surveillance and the impact of the war.
    Mohammad Y; Rafea S; Latifeh Y; Haydar T; Jamal H; Alkhayer G; Dib G; Al-Massalmeh MS; Al-Lahham A; Fawaz Y; Nahas LD; El Sony A; Ellwood P
    J Thorac Dis; 2023 May; 15(5):2873-2881. PubMed ID: 37324099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Study of Asthma and Allergies in Childhood (ISAAC): objectives and methods; results from German ISAAC centres concerning traffic density and wheezing and allergic rhinitis.
    Keil U; Weiland SK; Duhme H; Chambless L
    Toxicol Lett; 1996 Aug; 86(2-3):99-103. PubMed ID: 8711784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the prevalence and severity of symptoms of asthma changed among children in New Zealand? ISAAC Phase Three.
    Asher MI; Stewart AW; Clayton T; Crane J; Ellwood PI; Mackay R; Mitchell E; Moyes C; Pattemore PK; Pearce N
    N Z Med J; 2008 Oct; 121(1284):52-63. PubMed ID: 18953387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of asthma, rhinitis and eczema in children from the Bangkok area using the ISAAC (International Study for Asthma and Allergy in Children) questionnaires.
    Vichyanond P; Jirapongsananuruk O; Visitsuntorn N; Tuchinda M
    J Med Assoc Thai; 1998 Mar; 81(3):175-84. PubMed ID: 9623008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.